# Continue Entecavir Rollover From China

> **NCT00975091** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 600 (actual)

## Conditions studied

- Chronic Hepatitis B Virus

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT00975091
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2010-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975091, "Continue Entecavir Rollover From China". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00975091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*